Vaccines hope takes Bavarian Nordic's share price to more than 300 DKK
Monday saw lots of activity on Bavarian Nordic equity. According to a Danish bank analyst this owes to the potential of the firm's Covid-19 vaccine and a new order for the firm's smallpox vaccine.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
A Canadian order for smallpox vaccines worth DKK 195m (USD 31.3m) and continued speculation surrounding Bavarian Nordic's Covid-19 vaccine's glorious future has caused its share price to skyrocket in early Monday trading.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
.jpg&w=384&q=75)
